Trial
NCT03576963
Guadecitabine and Nivolumab in Treating Refractory Metastatic Colorectal Cancer
Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
University of Southern California
Collaborators
National Cancer Institute (NCI); Bristol-Myers Squibb; Astex Pharmaceuticals, Inc.
Condition
Colorectal Adenocarcinoma
Intervention
Guadecitabine
Why stopped
No funding
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-04-05